Sage Therapeutics, Inc. (NASDAQ:SAGE – Get Free Report) was the recipient of some unusual options trading on Monday. Stock investors purchased 7,666 call options on the company. This is an increase of 355% compared to the typical volume of 1,685 call options. Sage Therapeutics Stock Up 13.0 % Shares of NASDAQ SAGE opened at $18.93 […]
uniQure (NASDAQ:QURE – Free Report) – Equities researchers at HC Wainwright upped their Q3 2023 earnings estimates for uniQure in a note issued to investors on Thursday, August 3rd. HC Wainwright analyst P. Trucchio now anticipates that the biotechnology company will post earnings of ($1.34) per share for the quarter, up from their previous forecast […]
William Blair reiterated their outperform rating on shares of Axsome Therapeutics (NASDAQ:AXSM – Free Report) in a research note issued to investors on Monday morning, RTT News reports. A number of other analysts have also issued reports on the company. Mizuho boosted their price target on Axsome Therapeutics from $84.00 to $95.00 in a report […]
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Get Free Report) CFO Steven Pfanstiel sold 2,790 shares of the business’s stock in a transaction dated Monday, August 7th. The shares were sold at an average price of $9.54, for a total transaction of $26,616.60. Following the completion of the sale, the chief financial officer now owns 49,338 shares […]
Agios Pharmaceuticals (NASDAQ:AGIO – Free Report) had its price target reduced by JPMorgan Chase & Co. from $33.00 to $32.00 in a research report released on Monday, Benzinga reports. They currently have a neutral rating on the biopharmaceutical company’s stock. Other analysts have also issued research reports about the stock. SVB Securities decreased their price […]